Healthcare Wire News
Categories
- 409a valuations (13)
- appraisal standards and regulations (192)
- bankruptcy (65)
- business valuation accrediting organizations (85)
- business valuation certification (17)
- business valuation standards & regulations (11)
- buy/sell agreement (37)
- case law & expert testimony (2)
- case law analysis (440)
- commercial litigation (46)
- company-specific risk (39)
- compensation (20)
- cost of capital (122)
- daubert (93)
- discount for lack of marketability (DLOM) (89)
- discount for minority interest (22)
- discounts & premiums (142)
- dissenting shareholder (29)
- economic damages & lost profits (213)
- economic data for valuations (7)
- equity risk premia (39)
- ESOP valuations (39)
- estate and gift taxation (107)
- expert testimony (246)
- fair market value (FMV) (12)
- fair value for financial reporting (59)
- fair value proceeding (19)
- federal taxation (51)
- forensic accounting (7)
- global business valuation (95)
- going-concern value (14)
- goodwill (58)
- guideline public company method (30)
- healthcare (164)
- income approach (50)
- industry analysis (130)
- intangibles (389)
- intellectual property (1094)
- intellectual property valuation (1)
- judicial dissolution (5)
- legislation (68)
- licensing (223)
- M&A valuations (29)
- management forecasts (16)
- marital dissolution/divorce (130)
- market approach (30)
- option price modeling (10)
- patents (467)
- practice management and growth (103)
- private company transaction data (52)
- public company comps (24)
- purchase price allocation (61)
- reasonable royalty (86)
- royalty (78)
- S corps (24)
- securities litigation (26)
- shareholder oppression (13)
- standards of value (5)
- statutory appraisal action (20)
- tax affecting (18)
- tax valuations (47)
- technology transfer (60)
- trade secrets (61)
- trademark (118)
- transfer pricing (21)
- valuation experts (120)
- valuation method (105)
- valuation methods & approaches (4)
- valuation of minority interests (7)
- valuation profession news (221)